ArticleLung2026

Author's Response to: Nebulised Heparin for Lung Disease: Three Overlooked Risks that Merit Study Before Chronic Clinical Use.

Margarid Miranda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.